Medication info

Prednisolone Acetate Eye Drops

Prescription medicationEye dropsEye drops
Ingredient · strength
Prednisolone Acetate›10mg / 1mL
Manufacturer / importer
Kookje Pharmaceutical Co., Ltd.
Appearance
A white, opaque suspension in a container
Packaging
10 milliliters/bottle
Approval status
Active

MFDS item code 201906306 · Notified 2019.09.04 · Insurance code 643704761

Summary

Main use
Treatment of ocular inflammation (conjunctivitis, keratitis, etc.) and postoperative inflammation
Who applies the drops
Adults
Adult eye dose
Instill 1-2 drops per dose, 2-4 times daily. During the first 1-2 days, it may be used hourly if needed. Adjust as appropriate according to symptoms.

Ingredients

Manufacturer
Kookje Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of ocular inflammation (conjunctivitis, keratitis, etc.) and postoperative inflammation

  • Blepharitis
  • conjunctivitis
  • keratitis
  • scleritis
  • uveitis
  • post-surgical inflammation
View approved original text

This medication is used to treat various inflammatory conditions of the eye, including blepharitis, conjunctivitis, keratitis, scleritis, and uveitis, as well as inflammation that may occur after surgery.

How to apply drops

Adult eye dose

Instill 1-2 drops per dose, 2-4 times daily. During the first 1-2 days, it may be used hourly if needed. Adjust as appropriate according to symptoms.

Precautions

This medication should not be used in patients with viral kerato-conjunctivitis, fungal ocular diseases, ocular tuberculosis, untreated purulent infections, and who are hypersensitive to this drug. In patients with corneal epithelial detachment or ulceration, administration should be avoided due to the risk of corneal perforation. In glaucoma patients or children, use should be cautious considering the possibility of adrenal suppression. Various adverse reactions may occur with this drug, including headache, allergic reactions, eye pain, increased intraocular pressure, cataract, blurred vision, and eye redness, requiring caution. Long-term use may increase the risk of glaucoma or cataracts; therefore, regular intraocular pressure checks and lens examinations are necessary. Furthermore, patients with a history of herpes simplex should be monitored frequently to prevent exacerbation of corneal disease. In cases of acute purulent infection, this drug may mask or worsen symptoms, requiring caution. Contact lens wearers should remove lenses before instillation and can reinsert them at least 15 minutes after. If inflammation or pain persists or worsens for more than 48 hours, discontinue use immediately and consult a physician. Temporary blurred vision may occur during instillation, so driving or the operation of hazardous machinery should be avoided. If infected with chickenpox or measles during the use of this medication, severe complications may arise, necessitating prompt medical attention for infection prevention and symptom onset. Long-term use may delay wound healing or lead to pituitary and adrenal function suppression, requiring caution. Regarding drug interactions, concomitant use with anticholinergic agents such as atropine may lead to increased intraocular pressure, and the concurrent use of CYP3A inhibitors may increase the risks of systemic adverse effects, thus requiring caution. Pregnant or nursing women should exercise caution when using this medication and, if possible, avoid prolonged use. Children and the elderly require additional attention due to decreased physiological function. In cases of overdose, significant problems are unlikely; however, if overdosing occurs, it is advisable to drink water to dilute. This medication is for ophthalmic use only, and care should be taken to prevent contamination by ensuring the container tip does not contact the eye or other surfaces. Additionally, it is safest not to share this medication with others. When storing, keep in a tightly sealed container away from children, in a cool, dry place, avoiding direct sunlight, and do not transfer to another container.

Side effects

  • hypersensitivity
  • urticaria
  • headache
  • increased intraocular pressure
  • cataract
  • ocular penetration
  • foreign body sensation
  • eye congestion
  • eye infection
  • eye irritation
Show 15 more
  • blurred vision
  • visual impairment
  • dilation
  • eye pain
  • acute anterior uveitis
  • keratitis
  • conjunctivitis
  • corneal ulcer
  • corneal softening
  • conjunctival hemorrhage
  • ptosis
  • accommodation paralysis
  • dysgeusia
  • pruritus
  • rash

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is important to maintain storage temperatures between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

A white, opaque suspension in a container

Package unit

10 milliliters/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.